L-methylfolate can Reduce HHCY

L-methylfolate can Reduce HHCY

Methylfolate, the active form of folic acid, plays a role in converting homocysteine into methionine (a harmless amino acid), so if methylfolate is lacking due to the MTHFR mutation and subsequent inability to convert folic acid to methylfolate, homocysteine can build up to dangerous levels.

Magnafolate^® is a patented trademark of C-crystalline form of Calcium L-5-Methyltetrahydrofolate, produced under US Patent No. 9,150,982 B2, the most safe folate yet.

A quick overview:

Patented product-- C-crystal structure calcium salt..

3 years stability at room temperature..

FDA/NDI 920, Self Affirmed GRAS..

Kosher, Halal, GMP certificate

Magnafolate® ,the Manufacturers & Supplier of active folate.

Previous:New Player In Folate Industry Next:The Impact of 6S-5-Methyltetrahydrofolate on Endothelial Cell Function During Pregnancy and Its Potential in the Treatment of Gestational Hypertension

TOP